Epi proColon

System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection

FDA Premarket Approval P130001 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a manufacturing site located at sentinel ch. Spa, via robert koch, 2, 20152, milan, italy

DeviceEpi proColon
Classification NameSystem, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
Generic NameSystem, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
ApplicantEPIGENOMICS AG
Date Received2016-04-29
Decision Date2016-11-18
PMAP130001
SupplementS001
Product CodePHP
Advisory CommitteePathology
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonLocation Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address EPIGENOMICS AG geneststr.5 berlin 

Supplemental Filings

Supplement NumberDateSupplement Type
P130001Original Filing
S007 2021-06-21 Real-time Process
S006
S005 2019-08-06 30-day Notice
S004 2018-02-20 30-day Notice
S003
S002 2016-05-10 Normal 180 Day Track No User Fee
S001 2016-04-29 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
04260400670036 P130001 000
04260400670029 P130001 000
04260400670012 P130001 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.